Interpace Biosciences, Inc. (IDXG) has a market capitalization of $9.73M and trades at $2.20. The 52-week range is 0.443-2.01.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of 0.4, Earnings Per Share (EPS) of $5.55, annual revenue of $38.73M.
The stock has a beta of 0.97, operates in the Healthcare sector.
